Choose Search Scope Search KU Web Search KU People Search KU Events Search KU Info

Nancy Muma

Professor and Chair of Pharmacology and Toxicology

(785) 864-4002

• 1985 Ph.D. Pharmacology, University of Louisville
• Post-doctoral Fellowship, Johns Hopkins University School of Medicine

The most rewarding aspect of my job is mentoring young scientists. I have enjoyed mentoring 11 graduate students and numerous post-doctoral fellows. These scientists have gone on to become faculty members in academic institutions, scientists in pharmaceutical companies, scientific advisors to patent law firms, and scientific writers. Others are currently continuing their education in post-doctoral positions at Stanford University and Vanderbilt University.

I have a long standing interest in neurobiology. My B.A. is in psychobiology; I have an M.A. degree in neuropsychopharmacology and a Ph.D. pharmacology. I did my post-doctoral training at The Johns Hopkins University School of Medicine in the Pathology Department under the mentorship of Donald Price focusing on Alzheimer's disease. After two additional years as assistant professor at Johns Hopkins School of Medicine, I moved to Loyola University Chicago School of Medicine in the Department of Pharmacology. I sat on numerous Study Sections for NIH and was recently a member of the Molecular Neuropharmacology and Signaling Study Section. From 2005 until 2008, I have the honor of being a member of the editorial board for the Journal of Neuropathology and Experimental Neurology. In January 2007, I took a position as the Chair of the Department of Pharmacology and Toxicology in the School of Pharmacy at the University of Kansas. I was fortunate enough to have about half of my lab group move with me and appreciate the efforts of these loyal folks in making the transition.

We are currently in the process of building the Department of Pharmacology and Toxicology to develop cores of expertise in three focus areas 1) neurodegeneration, 2) mood disorders and addiction and 3) neural control of energy metabolism and neural effects of diabetes. With this approach, we hope to obtain collaborative funding in addition to the program project grant currently headed up by Dr. Elias Michaelis on neurodegeneration.

Find out more about the Muma Lab.

Publications (click here):